
Saudi Arabia Blood Collection Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.

Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The Saudi Arabia blood collection market size was estimated at USD 85.5 million in 2024. The market is expected to grow from USD 89.4 million in 2025 to USD 138.7 million in 2034, growing at a CAGR of 5%, according to the latest report published by Global Market Insights Inc.

The growth of the blood collection market is largely influenced by the high prevalence of genetic blood disorders such as thalassemia and sickle cell anemia, road traffic accidents and trauma cases, expansion of healthcare infrastructure, and increasing surgical procedures and emergency care. A blood collection device is a medical tool which is designed to draw blood samples safely and efficiently for diagnostic testing, transfusions, or research purposes. These devices play a vital role in clinical settings and are widely used across hospitals, laboratories, and blood banks. Major players in the Saudi Arabia blood collection industry include Becton, Dickinson and Company, Fresenius, Terumo Corporation, McKesson Corporation, and Nipro Corporation.
The market increased from USD 75.5 million in 2021 to USD 81.9 million in 2023. The growth of the blood collection market in Saudi Arabia is driven by the expansion of healthcare infrastructure under Vision 2030. By building new hospitals, modernizing existing ones, and creating specialized care facilities, the secondary capabilities of current healthcare systems drive the demand for complex blood collection methodologies. Other factors accompanying healthcare expansion include the associated rise in surgical volume, improvements in emergency care networks, and digital health integration, all of which necessitate the advanced blood collection tools required to support diagnostics, transfusions, and biobanking.
The high incidence of genetic blood disorders, such as thalassemia and sickle cell anemia, is accelerating the growth of the market. For instance, according to the Ministry of Health, in Saudi Arabia, about 4.2% of the population carries the sickle-cell trait, and 0.26% has sickle-cell disease. The highest prevalence is in the Eastern province, where approximately 17% of the population carries the gene, and 1.2% have sickle-cell disease. Sickle cell anemia significantly increases the need for blood collection products due to the nature of the disease, which causes chronic anemia that often require regular blood transfusions. Patients with sickle cell disease undergo routine blood tests to monitor hemoglobin levels, organ function, and detect complications. This creates consistent demand for blood collection tubes, sterile needles, and blood bags. Thus, this growing demand for blood collection is expected to significantly propel the growth of the market.
Additionally, increasing road traffic accidents and trauma care across Saudi Arabia have also emerged as key catalysts accelerating the growth of the blood collection market. For instance, according to the Ministry of Health, in 2020, individuals aged 19-30 accounted for the highest number of road injuries in Saudi Arabia, with 7,596 cases, followed by 6,527 injuries among those aged 31-40. Children and adolescents under 18 experienced 3,202 injuries, highlighting a significant burden of accident injuries across all age groups. These statistics underscore the critical role of blood collection systems in trauma care, as the high volume of road injuries continues to occur.
Blood collection is the process of collecting blood samples from a patient for diagnostic, therapeutic, or research purposes. Blood is collected through venous or capillary methods, depending on the volume required and the type of test. The procedure involves using various tools and devices, such as needles, syringes, lancets, blood collection tubes, and automated systems, to ensure safe, sterile, and accurate sample acquisition.

The Saudi Arabia market was valued at USD 75.5 million in 2021. The market size reached USD 81.9 million in 2023, from USD 78.5 million in 2022. Based on the product type, the blood collection market is segmented into system and consumables. The consumables segment accounted for 76.8% of the market in 2024 due to their precise sample collection and ability to support various types of blood tests. The segment is expected to reach USD 105.9 million by 2034, growing at a CAGR of 4.9% during the forecast period. On the other hand, the system segment is expected to grow with a CAGR of 5.2% from 2025 to 2034. The growth of this segment can be attributed to the rising demand for systems that improve efficiency, reduce contamination risks, and enhance patient comfort. As healthcare professionals seek faster and safer ways to collect blood samples, these systems are becoming an essential part of the modern diagnostic workflows.
Based on the method, the Saudi Arabia blood collection market is segmented into manual blood collection and automated blood collection. The automated blood collection segment accounted for the market share of 47.1% in 2024.
Based on application, the Saudi Arabia blood collection market is segmented into diagnostics, treatment, and research. The diagnostics segment accounted for the highest market share of 50.2% in 2024 due to the increasing number of diagnostic procedures requiring blood samples, including disease screenings and chronic condition monitoring such as diabetes, cardiovascular diseases, and cancer.

Based on end use, the Saudi Arabia blood collection market is segmented into hospitals and clinics, diagnostic centers, blood banks, and academic and research institutes. The hospitals and clinics segment accounted for the highest market share of 37% in 2024 due to their role as primary healthcare providers managing a high number of patients requiring routine blood tests, emergency diagnostics, and pre- and post-operative assessments.
Some of the eminent market participants operating in the Saudi Arabia blood collection industry include:
BD’s centers on its engineering expertise and patient centric innovation. The company’s FDA cleared MiniDraw capillary blood collection system, enables lab quality testing from fingertip samples, offering a less invasive alternative to traditional venous draw. BD also leads with its Vacutainer range, a gold standard in specimen management, reinforcing its dominance in clinical diagnostics.
Terumo stands out with its global reach and advanced blood collection technologies. The company offers a comprehensive portfolio of high-quality blood bags with advanced donor safety features, sterile docking options, and biocompatible materials.
The Company’s MiniCollect capillary blood collection system is tailored for pediatric, geriatric, and patients with fragile veins, enabling high-quality sampling with minimal invasiveness. Greiner also leads with its VACUETTE range of evacuated blood collection tubes made from virtually unbreakable PET plastic setting the benchmark for safety and precision in specimen handling across hospitals and laboratories in the region.
Market, By Product Type
Market, By Method
Market, By Application
Market, By End Use
The market size was estimated at USD 85.5 million in 2024.
The market is projected to reach USD 89.4 million in 2025 as demand continues to rise across healthcare facilities.
The market is expected to grow to USD 138.7 million by 2034, expanding at a CAGR of 5% during the forecast period.
The consumables segment dominated the market with 76.8% share in 2024, supported by strong demand for blood collection tubes, lancets, needles, syringes, and blood bags used in routine testing and transfusions.
The system segment, including both automated and manual devices, is projected to grow at a 5.2% CAGR from 2025 to 2034 due to rising demand for efficiency, safety, and reduced contamination risk in clinical workflows.
Automated blood collection accounted for 47.1% of the market share in 2024, reflecting growing adoption of precision systems across hospitals, trauma centers, and blood banks.
The diagnostics segment led the market with 50.2% share in 2024, driven by increasing disease screening, chronic condition monitoring, and preventive healthcare testing.
Hospitals and clinics accounted for the largest end-use share at 37% in 2024, due to high volumes of routine testing, emergency diagnostics, and pre- and post-operative blood assessments.
The leading companies include Becton, Dickinson and Company, Fresenius, Terumo Corporation, McKesson Corporation, and Nipro Corporation, which together held a collective market share of 40% in 2024.


